%0 Journal Article
%K Female
%K Humans
%K Adolescent
%K Glomerulonephritis
%K Immunologic Factors
%K Rituximab
%B Nephrology (Carlton)
%D 2017
%G eng
%N 3
%P 265
%R 10.1111/nep.12757
%T Successful treatment of C1q nephropathy with CD19 targeted Rituximab therapy.
%V 22